Lou Lieto

Wilson Sonsini Goodrich & Rosati

+ Follow Contact

Latest Posts › Centers for Medicare & Medicaid Services (CMS)

Share:

The Inflation Reduction Act’s Medicare Price Negotiation Program: Two Years Later

The Inflation Reduction Act (the Act) of 2022 was controversial at the time the Act was signed into law and remains so. To date, multiple legal challenges have been asserted against the Act, with more expected in the future....more

11/21/2024 / Centers for Medicare & Medicaid Services (CMS) , Drug Pricing , Healthcare Reform , Inflation Reduction Act (IRA) , Medicare , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

Prescription Drug Provisions in the Inflation Reduction Act of 2022

The Inflation Reduction Act of 2022 (the Act) includes prescription drug provisions that have significant implications for the pharmaceutical industry and Medicare beneficiaries, such as allowing the U.S. Department of Health...more

8/30/2022 / Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Medicare , Medicare Part B , Medicare Part D , Pharmaceutical Industry , Prescription Drugs

The Life Sciences Report - Spring 2013

In this issue: - Best Patent Practices Under the America Invents Act - CMS Issues Final Rule for Implementing Sunshine Act - New IP Litigation Team a Boon for Firm's Life Sciences and Technology...more

6/12/2013 / America Invents Act , Centers for Medicare & Medicaid Services (CMS) , Civil Monetary Penalty , Final Rules , Mayo Foundation for Medical Ed , Mayo v. Prometheus , Patent Reform , Patents , Sunshine Act , Venture Capital

3 Results

View per page

Page: of 1